Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/29/2025

Diagnosis and Evidence‑Based Management of Recurrent Bartholin Gland Cysts

Initial Evaluation

  • Bartholin glands are anatomically situated at the 4 o’clock and 8 o’clock positions within the posterior vestibule of the vulvar vestibule. 1
  • Clinical signs suggesting infection of a Bartholin cyst include erythema, swelling, tenderness that may extend into the labia minora, and purulent drainage. 1
  • When a cyst recurs at the same site, clinicians should consider alternative diagnoses such as a pilonidal cyst, hidradenitis suppurativa, or retained foreign material. 2
  • Early microbiological sampling is recommended because Bartholin gland infections are frequently caused by sexually transmitted pathogens, most commonly Neisseria gonorrhoeae and Chlamydia trachomatis. [1][2]

Microbiological Management of Recurrent Disease

  • For cysts that recur after initial definitive treatment, obtain a culture and prescribe a 5‑ to 10‑day course of an antibiotic active against the isolated organism. 2
  • In cases of recurrent Staphylococcus aureus infection, a decolonization protocol is advised: intranasal mupirocin twice daily for 5 days, daily chlorhexidine body washes, and routine cleaning of personal items. 2

Antibiotic Considerations

  • Antibiotics serve as adjunctive therapy; they should be administered in addition to adequate drainage when an infection is present. Coverage must include the common STI pathogens (N. gonorrhoeae and C. trachomatis). 1
  • If systemic signs of infection (e.g., fever, tachycardia, meeting SIRS criteria) are evident, antimicrobial regimens should be broadened to include activity against Staphylococcus aureus, including MRSA when risk factors exist. 2

Prevention of Missed STI

  • Routine cultures for gonorrhea and chlamydia are essential in infected Bartholin cysts to avoid overlooking an underlying sexually transmitted infection. 1